NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug ...

Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...

With just one asset in weight loss moving through the clinic, Pfizer targets the space for potential dealmaking, as well as bringing assets over from China.

Following oral administration of a drug, extent and speed of absorption is influenced by several processes ... view of the observed differences in the pharmacokinetic profiles for sugar-coated ...

Detailed price information for Thiogenesis Therapeutics Corp (TTI-X) from The Globe and Mail including charting and trades.

To that end, we conducted a series of human and animal studies which produced extremely encouraging pharmacokinetic ... We have begun the process of amending Human Study #4 (GLP-1-H24-4) to include ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

To that end, we conducted a series of human and animal studies which produced extremely encouraging pharmacokinetic ... We have begun the process of amending Human Study #4 (GLP-1-H24-4) to include ...

Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.